Epstein Secrets

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

herapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National Institutes of Health officials to meet with a staffer from that company. At least as troubling are the actions Collins took that were not deemed to be ethical violation

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

herapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National Institutes of Health officials to meet with a staffer from that company. At least as troubling are the actions Collins took that were not deemed to be ethical violation

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

herapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National Institutes of Health officials to meet with a staffer from that company. At least as troubling are the actions Collins took that were not deemed to be ethical violation

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

herapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National Institutes of Health officials to meet with a staffer from that company. At least as troubling are the actions Collins took that were not deemed to be ethical violation

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. EFTA00085695 The office also said Collins may have broken House ethics rules by persuad

Australian biotech firm, based on inside information. EFTA00085695 The office also said Collins may have broken House ethics rules by persuading National Institutes of Health officials to meet with a staffer from that company. At least as troubling are the actions Collins took that were not deemed to be ethical violation